Gene · 9760
Papers2,030
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,030
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD226 identifies functional CD8+T cells in the tumor microenvironment and predicts a better outcome for human gastric cancer. | Front Immunol | 2023 | 37056782 | PubTator, text mining | PubMed |
| Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics. | J Clin Invest | 2023 | 37053016 | PubTator, text mining | PubMed |
| Fibroblasts as Turned Agents in Cancer Progression. | Cancers (Basel) | 2023 | 37046676 | PubTator, text mining | PubMed |
| Dynamics and specificities of T cells in cancer immunotherapy. | Nat Rev Cancer | 2023 | 37046001 | PubTator, text mining | PubMed |
| Expansion of circulating stem-like CD8+ T cells by adding CD122-directed IL-2 complexes to radiation and anti-PD1 therapies in mice. | Nat Commun | 2023 | 37045833 | PubTator, text mining | PubMed |
| Genomic Epidemiology of Corynebacterium diphtheriae in New Caledonia. | Microbiol Spectr | 2023 | 37042786 | PubTator, text mining | PubMed |
| Machine learning-based construction of immunogenic cell death-related score for improving prognosis and response to immunotherapy in melanoma. | Aging (Albany NY) | 2023 | 37036471 | PubTator, text mining | PubMed |
| Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell Lymphoma. | Mol Cancer | 2023 | 37032358 | PubTator, text mining | PubMed |
| Cross-platform dataset of multiplex fluorescent cellular object image annotations. | Sci Data | 2023 | 37029126 | PubTator, text mining | PubMed |
| Systems biology approaches to unravel lymphocyte subsets and function. | Curr Opin Immunol | 2023 | 37028221 | PubTator, text mining | PubMed |
| Favorable Immunotherapy Plus Tyrosine Kinase Inhibition Outcome of Renal Cell Carcinoma Patients with Low CDK5 Expression. | Cancer Res Treat | 2023 | 37024096 | PubTator, text mining | PubMed |
| The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies. | Front Immunol | 2023 | 37020537 | PubTator, text mining | PubMed |
| Type I Interferon Signaling via the EGR2 Transcriptional Regulator Potentiates CAR T Cell-Intrinsic Dysfunction. | Cancer Discov | 2023 | 37011008 | PubTator, text mining | PubMed |
| Migration of stem-like CD8 T cells between tissue microenvironments underpins successful anti-tumour immune responses. | Discov Immunol | 2023 | 37008996 | PubTator, text mining | PubMed |
| A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma. | Front Immunol | 2023 | 37006314 | PubTator, text mining | PubMed |
| Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade. | Cancer Cell | 2023 | 37001526 | PubTator, text mining | PubMed |
| Epigenetic regulation of HBV-specific tumor-infiltrating T cells in HBV-related HCC. | Hepatology | 2023 | 36999652 | PubTator, text mining | PubMed |
| C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma. | Front Genet | 2023 | 36992705 | PubTator, text mining | PubMed |
| Studying T Cell Responses to Hepatotropic Viruses in the Liver Microenvironment. | Vaccines (Basel) | 2023 | 36992265 | PubTator, text mining | PubMed |
| Identification of HPV16 E1 and E2-specific T cells in the oropharyngeal cancer tumor microenvironment. | J Immunother Cancer | 2023 | 36990508 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9760/papers?page=29